Switch to
More onapp

Chandra Bhagat Pharma Ltd

CBPL
Trading
SmallcapWith a market cap of ₹76 cr, stock is ranked 2,391
Moderate RiskStock is 2.99x as volatile as Nifty
95.001.50 (-1.55%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Trading
SmallcapWith a market cap of ₹76 cr, stock is ranked 2,391
Moderate RiskStock is 2.99x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
95.73
PB RatioPB Ratio
2.87
Dividend YieldDiv. Yield
Sector PESector PE
85.86
Sector PBSector PB
10.97
Sector Div YldSctr Div Yld
0.58%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Chandra Bhagat Pharma Ltd is an India-based medicine company. The Company is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. It provides a range of products portfolio of a pharmaceutical formulation including injections (ampoules, vials, prefilled syringe, lyophilized vials), tablet, capsules and oral syrup. The Company’s products include for the domestic market mufost, mufost, herzovir, herzovir, clauvmentin, falsun, azap, azocin, chinofen, polodyl, casfungen, cbtaz, nuperazone, nuperazone forte, nuperazone plus, nuperazone 3g, cefzidime tz, cefzidime, cezoneplus, cezone tz, myocholine, klarinton, samcy, dobier s, maxiparine, antacer, cbfos, thionine, thromboparin, meplife combipack, merospect and norepirin.

Financial TrendFinancial statements 

2019202020212022106.7294.4271.1895.700.700.310.200.80
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.02%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events